"Successful automation depends on orchestration, not just robotics," notes Werner Maas, PhD, CEO, Hudson Lab Automation.
Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug ...
Synfini, Inc., provider of the industry's most advanced Agile AI Foundry for drug discovery, today announced the integration ...
“ The Carterra Vega platform is a technological leap forward—a true step change. Faster hit discovery with 48 parallel ...
Discover the collaboration between Synthace and Charles River to enhance assay development and improve reproducibility in ...
Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.
Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
Researchers have discovered a previously unknown enzyme that plays a crucial role in fat production. By blocking it, they stopped weight gain, reduced liver damage, and lowered harmful cholesterol ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial intelligence framework to rapidly generate drug-like molecules that are easier to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results